Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02ALK
|
||||
Former ID |
DNC005716
|
||||
Drug Name |
6-Pyridin-3-yl-naphthalen-2-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527801] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H11NO
|
||||
Canonical SMILES |
C1=CC(=CN=C1)C2=CC3=C(C=C2)C=C(C=C3)O
|
||||
InChI |
1S/C15H11NO/c17-15-6-5-11-8-12(3-4-13(11)9-15)14-2-1-7-16-10-14/h1-10,17H
|
||||
InChIKey |
MDXMZUQFVFTPDO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | |
17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527801] | ||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Steroid Biosynthesis | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.